Real-world performance of diagnostic testing for coccidioidal meningitis in initial sampling of the cerebrospinal fluid
Medical Mycology · 2025
DOI: 10.1093/mmy/myaf082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Niriksha Ravi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Bronxcare Health System, New York, USA. Hauptthemen laut MEDLINE: Coccidioidomycosis, Meningitis, Fungal, Diagnostic Tests, Routine, Cerebrospinal Fluid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Early diagnosis and treatment are essential for improving outcomes of coccidioidal meningitis. While the detection of IgG by serologic testing of the cerebrospinal fluid (CSF) has been a mainstay of diagnosis for years, the diagnosis of coccidioidal meningitis in clinical practice can be very challenging due to suboptimal sensitivity of laboratory tests. We reviewed the results of the CSF diagnostic test results from the initial lumbar puncture in 110 patients with proven, probable, and likely coccidioidal meningitis from 1989 to 2024. One hundred four patients were diagnosed with coccidioidal meningitis on the initial CSF examination. The positivity rate of the first CSF testing was 89.1% (n = 64) for IgG by enzyme immunoassay, 62.2% (n = 98) for IgG by immunodiffusion, and 70.2% (n = 104) for IgG by complement fixation, 4.4% (n = 90) for fungal culture, 18.8% (n = 69) for polymerase chain reaction, and 33% (n = 21) for Coccidioides antigen. The non-specific fungal marker 1,3-β-d-glucan was positive in the CSF in 70.4% (n = 27) of samples. Contrasted brain magnetic resonance imaging identified leptomeningeal enhancement in 53.1%. Optimal detection of coccidioidal meningitis requires a combination of diagnostic modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Bronxcare Health System, New York, USA.
- Department of Internal Medicine, Banner University, Phoenix, Arizona, USA.
- Division of Infectious Diseases, Southern Illinois Healthcare, Carbondale, Illinois, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Department of Neurology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Department of Medicine, Division of Infectious Diseases, Mayo Clinic Arizona, Phoenix, Arizona, USA.
ORCID-Profile: Niriksha Ravi, Rawan Elkurdi, Alexander J Lietz, Thomas Grys, Marie Grill, Janis E Blair
Zitieren
APA
Ravi, N., Elkurdi, R., Lietz, A. J., Grys, T., Grill, M., & Blair, J. E. (2025). Real-world performance of diagnostic testing for coccidioidal meningitis in initial sampling of the cerebrospinal fluid. Medical Mycology. https://doi.org/10.1093/mmy/myaf082
Vancouver
Ravi N, Elkurdi R, Lietz AJ, Grys T, Grill M, Blair JE. Real-world performance of diagnostic testing for coccidioidal meningitis in initial sampling of the cerebrospinal fluid. Medical Mycology. 2025. doi:10.1093/mmy/myaf082
BibTeX
@article{Ravi2025,
author = {Ravi, Niriksha and Elkurdi, Rawan and Lietz, Alexander J and Grys, Thomas and Grill, Marie and Blair, Janis E},
title = {Real-world performance of diagnostic testing for coccidioidal meningitis in initial sampling of the cerebrospinal fluid},
journal = {Medical Mycology},
year = {2025},
doi = {10.1093/mmy/myaf082}
}
EUVIMED